Article Details
Retrieved on: 2021-08-13 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities decreased their target price on shares of PTC Therapeutics from $75.00 to $65.00 and set a "buy" rating on the stock in a research ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here